학술논문
Luspatercept Increases Hemoglobin and Reduces Transfusion Burden in Patients with Low-Intermediate Risk Myelodysplastic Syndromes (MDS): Long-Term Results from Phase 2 PACE-MDS Study
Document Type
Abstract
Author
Source
In Blood 2 December 2016 128(22):3168-3168
Subject
Language
ISSN
0006-4971